AMRN Amarin Corp Plc

Price (delayed)

$0.9645

Market cap

$396.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.15

Enterprise value

$205.05M

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
AMRN's debt is down by 13% year-on-year and by 2.6% since the previous quarter
AMRN's quick ratio is up by 5% since the previous quarter and by 2.9% year-on-year
AMRN's net income is up by 44% YoY but it is down by 13% from the previous quarter
The company's EPS rose by 42% YoY but it fell by 25% QoQ
Amarin's gross profit has decreased by 32% YoY and by 10% QoQ
AMRN's gross margin is down by 18% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
410.67M
Market cap
$396.09M
Enterprise value
$205.05M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.71
Price to sales (P/S)
1.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.67
Earnings
Revenue
$306.91M
EBIT
-$53.66M
EBITDA
-$50.7M
Free cash flow
$6.35M
Per share
EPS
-$0.15
Free cash flow per share
$0.02
Book value per share
$1.35
Revenue per share
$0.75
TBVPS
$1.99
Balance sheet
Total assets
$831.68M
Total liabilities
$279.59M
Debt
$8.74M
Equity
$552.1M
Working capital
$465.7M
Liquidity
Debt to equity
0.02
Current ratio
2.8
Quick ratio
1.75
Net debt/EBITDA
3.77
Margins
EBITDA margin
-16.5%
Gross margin
53.9%
Net margin
-19.3%
Operating margin
-22%
Efficiency
Return on assets
-7%
Return on equity
-10.5%
Return on invested capital
-15.2%
Return on capital employed
-9.4%
Return on sales
-17.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
-5.44%
1 week
-8.14%
1 month
11.57%
1 year
-29.08%
YTD
10.86%
QTD
8.27%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$306.91M
Gross profit
$165.54M
Operating income
-$67.59M
Net income
-$59.11M
Gross margin
53.9%
Net margin
-19.3%
AMRN's net income is up by 44% YoY but it is down by 13% from the previous quarter
AMRN's operating income is up by 36% year-on-year and by 7% since the previous quarter
AMRN's net margin is up by 33% year-on-year but it is down by 18% since the previous quarter
Amarin's gross profit has decreased by 32% YoY and by 10% QoQ

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
0.71
P/S
1.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.67
The company's EPS rose by 42% YoY but it fell by 25% QoQ
AMRN's P/B is 85% below its 5-year quarterly average of 5.1 and 6% below its last 4 quarters average of 0.8
The equity has declined by 7% year-on-year
The P/S is 71% less than the 5-year quarterly average of 4.7 and 3.6% less than the last 4 quarters average of 1.4
The revenue is down by 17% year-on-year and by 4.8% since the previous quarter

Efficiency

How efficient is Amarin business performance
The ROIC has increased by 43% YoY and by 16% QoQ
AMRN's ROE is up by 40% YoY but it is down by 15% from the previous quarter
The company's return on sales rose by 38% YoY and by 13% QoQ
Amarin's ROA has increased by 38% YoY but it has decreased by 15% from the previous quarter

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total assets is 197% greater than its total liabilities
AMRN's total assets is down by 6% year-on-year
The current ratio has grown by 5% YoY and by 4.1% from the previous quarter
AMRN's debt is 98% smaller than its equity
AMRN's debt is down by 13% year-on-year and by 2.6% since the previous quarter
The equity has declined by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.